Q2 2025 Phreesia Inc Earnings Call Transcript
Key Points
- Phreesia Inc (PHR) achieved positive free cash flow for the first time as a public company.
- Q2 revenue was $102.1 million, up 19% year over year.
- Adjusted EBITDA was $6.5 million, up $18 million year over year.
- Operating cash flow was positive at $11.1 million, up $20.4 million year over year.
- Phreesia Inc (PHR) is maintaining its revenue outlook for fiscal year 2025 at a range of $416 million to $426 million.
- Total revenue per healthcare services client (HSC) was $24,494, down 2% year over year.
- Q2 fiscal 2025 total revenue per HSC was flat year over year when compared to Q2 fiscal 2020.
- Sales and marketing expenses have been high, although they have trended down from a peak of $40 million to $30 million.
- The company faces variability in revenue from its Network Solutions segment, which adds uncertainty to financial projections.
- Phreesia Inc (PHR) has not provided specific guidance on the impact of new integrations and partnerships, such as with Meditech and Oracle EHR.
Good evening, ladies and gentlemen, and welcome to the Phreesia second-quarter fiscal 2025 earnings conference call. (Operator Instructions)
First, I would like to introduce, Balaji Gandhi, Phreesia's Chief Financial Officer. Mr. Gandhi, you may begin.
Thank you, operator. Good evening, and welcome to Phreesia earnings conference call for the second quarter of fiscal 2025, which ended on July 31, 2024. Joining me on today's call is Chaim Indig, our Chief Executive Officer.
A more complete discussion of our results can be found in our earnings press release and in our related Form 8-K submission to the SEC, including our quarterly stakeholder letter both issued after the market closed today. These documents are available on the Investor Relations section of our website at ir.phreesia.com. As a reminder, today's call is being recorded, and a replay will be available on our Investor Relations website at ir.phreesia.com, following the conclusion of the call.
During today's call, we
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
